I. INTRODUCTION
Liver, the largest internal organ of the body, performs more than 500 functions including metabolism, detoxification, homeostasis, protein synthesis, and bile production. Liver diseases are leading causes of death worldwide, accounting for ~ 1-2 million deaths annually. 1 Often associated with high mortality rates, liver failure can be categorized into acute liver failure and acute chronic liver failure (ACLF).
2, 3 The most prominent causes of ACLF include viral hepatitis, drug-induced liver injury, and autoimmune liver disease. End-stage liver disease usually results in irreversible deterioration of the liver. In these cases, liver transplantation is the only
Critical Reviews
TM in Biomedical Engineering and extracorporeal systems help in an environment that facilitates patient self-recovery, often creating a window of opportunity for liver transplantation. Hepatocyte transplantation is less invasive and can be performed repeatedly. Although transplantation of hepatocytes is an alternative to liver transplantation, insufficient numbers of functional hepatocytes for therapeutic efficacy hinder its practical application. Functional hepatocytes result in a low degree of engraftment (< 30%) and cannot restore long-term liver function. In addition, primary hepatocytes easily lose viability and hepatic function during in vitro culture or transplantation. 6 Novel technologies such as liver-on-chip 7 and bioprinted liver 8 have been proposed to produce an implantable in vitro liver and reliably predict in vivo-like tissue responses. For successful thick tissues with complex structure like that of liver, two major issues must be addressed regarding limitations of existing technologies. One is organization of a medium-delivering system or vascular-like structure in the engineered tissue for sufficient mass transfer. The other is realizing an adequate cell supply and stability of liver-specific functions to closely match those measured in vivo. 9 Therefore, various liver tissue-engineering approaches have been explored to stimulate a diseased liver to regenerate itself or provide a substitute such as a bioengineered liver that can perform all native liver functions. One approach described in the literature is the development of biomaterials such as polymer-based three-dimensional (3D) constructs, decellularized extracellular matrix (ECM) constructs, or bioprinting 3D constructs to mimic liver ECM and replicate various functions such as cell adhesion, viability, growth, and proliferation. Another approach is development of bioreactors to improve various functions of hepatocytes that are seeded into constructs. The application of a real 3D-microenvironment niche for cell attachment, growth, and proliferation could improve related liver metabolic and hepatic function. Liver-on-chip technologies have been developed that use a combination of bioreactor techniques and microfluidic devices to sustain the phenotype of hepatocytes and liver-specific functions in long-term culture. Such technologies provide for the detection of cell-cell interaction and drug screening under physiological or pharmaceutical testing conditions. Here, we describe several methods for regenerating liver tissue along with futuristic approaches to overcome hurdles in liver tissue engineering.
II. 3D CONSTRUCTS FOR LIVER TISSUE ENGINEERING
3D Biocompatible scaffolds ( Fig. 1 ; Table 1 ) play a critical part in cell-cell-based tissue engineering and provide space for cell movement, attachment, and an ECM-like environment for cell growth and differentiation. 10 During the last ten years, hepatocyte transplantation has been performed with varying degrees of success; the low liver-engraftment rate and limited survival during long-term cryopreservation undermine application. 10 Delivery of hepatocytes to the liver requires the appropriate vehicle and form. One such system is implantable tissue-engineered liver constructs. Hepatic tissue engineering has been achieved using different types of cells including mature hepatocytes, embryonic stem cells (ESCs), and mesenchymal stem cells (MSCs), along with biomaterials. 
A. Polymer-Based 3D Constructs
The formation of spheroids on low-attachment surfaces and on Matrigel (BD Biosciences; NJ, USA), which is rich in ECM proteins such as laminin and collagen and also contains epidermal growth factor and insulin-like growth factor, enhances functional characteristics of hepatocytes. Hepatocyte spheroids cultured in 3D biomaterial constructs showed improved functionality over cells grown on a 2D substrate. 4 A honeycomb-structured 3D scaffold prepared from poly(3-hydroxybutyrate-co-3-hydroxyvalerateco-3-hydroxyhexanoate), seeded with umbilical cordderived MSCs (UCMSCs) and UCMSC-derived hepatocyte-like cells, demonstrated significantly increased liver-like function in vivo.
10 3D Scaffolds of genipin cross-linked chitosan-gelatine 12 and macroporous chitosan-gelatin B microspheres 13 have shown superior penetration of cells along with cell proliferation, biocompatibility, and maintenance of liver-specific functions. 3D Collagen functionalized, microsphere templated, polyethylene glycol (PEG) hydrogel scaffolds that were seeded with hepatocarcinoma HuH-7.5 cells revealed improved liver-specific functions.
14 3D Polymer scaffolds such as dextran-gelatin, chitosan-hyaluronic acid, and gelatin-vinyl acetate cultured with UCMSCs showed improved differentiation of hepatocytes. However, UCMSCs could not generate hepatocytes without exogenous growth factor-like hepatocyte growth factor. 15 Human induced pluripotent stem cell (iPSC)-derived hepatocytes and endothelial cells (ECs) were encapsulated in the polyelectrolyte fibers of water-soluble chitin-galac tose and formed multi-interfacial polyelectrolyte complex (MIPC) fibers, consisting of four separate domains: ECs in two central domains and hepatocytes in outer domains. MIPCs were used to create a 3D polyelectrolyte hydrogel that subsequently assembled to form tissue-like constructs. The presence of ECs in the scaffold significantly improved hepatocyte function in vitro and in vivo and facilitated scaffold vascularization. The study showed methods for encapsulating cells within separate domains in multicomponent hydrogel and ways to assemble fibers to form 3D-patterned tissue constructs. 4 When engrafted with L02 cells, the 3D hydrogel (1% collagen + 1.5% chitosan) scaffold with a fabricated grid pattern significantly improved liver-specific functions even after 2 wk of in vivo transplantation in mice with partial hepactomy and radiation-induced liver damage. 16 Researchers used two different cryogels of copolymer of acrylonitrile and n-vinyl-2-pyrrolidone as well as interpenetrating polymer networks of chitosan and poly(n-isopropylacrylamide) (poly[NiPAAm])-chitosan that were fabricated by gelatin. Both cryogels supported in vitro growth and functions of CV-1 simian in origin 7 and Hep G2 cells. The cryogels were hemocompatible, and primary rat hepatocytes grown on poly(NiPAAm)-chitosan cryogel for 96 hr formed cellular aggregates and maintained functions and in vivo implantation in mice, illustrating biocompatibility with surrounding tissue. Off-line clinical evaluation of these cryogel-based bioreactors showed ability of immobilized cells to detoxify circulating plasma that was obtained from patients with ACLF.
17 Some limitations in current designs include conventional transport, nutritional gradients across the reactor, nonuniform seeding, inefficient immobilization, and poor hepatocyte growth. 17 In an earlier study, hepatocytes sustained albumin secretion for at least 3 wk at similarly high levels for a collagen and heparin gel sandwich culture system. The cytochrome P450 activity of albumin secretion of hepatocytes was greater in the heparin gel sandwich culture system than that in collagen gels.
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B. Decellularized 3D Constructs
Natural scaffolds derived from decellularized rat liver ECM 9 or 3D ECM derived from porcine liver discs 16 exhibit better cell infiltration, viability, and hepatic function of hepatocytes in vitro and in vivo. 6 Such improved function that could be due to cellcell and cell-ECM adhesion, interaction, and polarity has a significant role in regulation of cell morphology, proliferation, differentiation, and viability, 19 compared to hydrogel, collagen, or polystyrene cultureware or a collagen gel sandwich. 20 Rat livers were decellularized using a detergent (DET)-enzymatic technique with ethylenediaminetetraacetic acid (EDTA) (EDTA-DET) or without EDTA (DET). Both scaffolds showed preservation of the ECM matrix, with a greater amount of collagen and glycosaminoglycans in the EDTA-DET scaffold. DET scaffolds seeded with hepatocellular cells showed complete repopulation in 14 d. 21 Two different substrates of decellularized porcine liver included one with hydrochloric acid versus acetic acid and the other with ammonium hydroxide versus sodium deoxycholate. The culture of primary porcine hepatocytes on these scaffolds showed enhanced functionality, including albu-min and urea production and bile-canaliculi formation, compared to that of type I collagen. 22 Decellularized human liver cubic scaffolds that were seeded with hepatic stellate cells, hepatocellular carcinoma cells, and hepatoblastoma cells showed repopulation for 21 d with efficient viability, motility, and proliferation.
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C. 3D Printed Constructs
A novel 3D scaffold fabricated by the rapid prototyping technology of selective laser sintering using nylon-12 was designed using scalable culture chambers with a smooth branching network that homogeneously delivered medium throughout the construct. Cellular aggregates of cocultured Hep G2 and TMNK-1 cells were then used as microtissue units that were packed into the scaffold with poly-l-lactic acid fibers, showing enhanced cellular density, hepatic function, and viability after 9 d of perfusion culture. 9 Alginate gel and galactosylated alginate (GA) gel were fabricated using a custom-made inkjet 3D bioprinter. GA gel was found to be more suitable for hepatocyte attachment and culture. A new 3D cell culture system was developed as the sandwich culture device, fabricated by using two layers of hepatocytes on GA gel sheets. The cells in these devices expressed liver-specific markers such as albumin, multidrug resistance-associated protein 2, and asialoglycoprotein receptor. 19 Photopolymerizable PEG-based hydrogels were fabricated using stereolithography (STL) with multiple open channels including rectangles and ellipses. After 7 d of perfused culture, hydrogel scaffolds remained intact and primary hepatocytes exhibited liver-specific functions.
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III. BIOREACTOR SYSTEMS FOR LIVER REGENERATION
Bioreactors (Table 2 ) provide a similar condition to the microenvironment in vivo by maintaining hepatocyte function without toxicity. 12 Bioreactors exhibit high-efficiency cell seeding, greater cell-to-cell contact, prolonged viability, and improved functionality. 13 Of various bioreactors such as spinner flasks or rotating wall systems, a perfusion system shows potential application for bone tissue engineering. (Fig. 2) . 26 Highly porous biomaterial scaffolds could provide a 3D growth environment that would be beneficial to the viability of primary hepatocytes. However, living cells are mainly distributed in regions near the surface of the scaffolds due to nutrient and oxygen diffusion limitations. Therefore, it is necessary to incorporate microfluidic channels into the porous scaffolds to facilitate mass transportation within. 27 Rat hepatocytes were cultured on polydimethylsiloxane (PDMS) membrane for 14 d in monolayer culture, sandwich culture with Matrigel, and 3D culture with microporous expanded polytetrafluoroethylene membrane in the presence and absence of direct oxygenation from another side of the membrane. It was found that 3D culture performed increased functions that were comparable to those in sandwich culture. Oxygenation is a critical factor in the optimization of hepatocyte culture microenvironments. 28 Primary hepatocytes, the gold standard of drug hepatotoxicity screening, quickly lose hepatic function in vitro. Alternatives such as hepatoma cell lines or stem cell-derived hepatic-like cells face problems of early dedifferentiation. 29 In vitro 3D culture such as that in bioreactors or hydrogels could offer a biomimetic microenvironment to maintain hepatic functions of hepatocytes and promote hepatic differentiation of stem cells for drug screening and potential clinical treatments. 29 In an earlier study, 30 the potential of a dynamic 3D hollow fiber membrane bioreactor technology (a 3D multicompartment bioreactor) was compared using 2D culture to improve iPSC hepatic differentiation. Hepatic maturation of iPSC-derived hepatocyte-like cells (HLCs) improved in 3D bioreactors. However, only a few aspects of hepatic functionality were achieved, and fully maturated functional hepatocytes were not realized. 30 In another study, researchers hypothesized that 3D culture enhances hepatic functions via regulation of epithelial-mesenchymal transition (EMT) status. Biomaterial-engineered EMT was achieved by culturing HepaRG (Biopredic International; Alladdin, China) as 3D spheroids or 3D stretched cells in an adherent gelatin and nonadherent PEG diacrylatemicro scaffold, respectively. Improved expression of representative hepatic functional markers and epithelial markers and depression of mesenchymal markers occurred in 3D spheroid culture. 29 Organ decellularization is an attractive strategy due to its naturally occurring 3D biomimetic scaffold that is able to retain most native ECM proteins, biomolecules, and spatial organization. A cryochemical decellularization-generated 3D acellular liver scaffold from mouse whole liver supported hepatic differentiation of MSCs under whole-organ perfusion culture and hepatic-like tissue generation, offering the ability to act as functional grafts and rescue lethal hepatic failure after transplantation in vivo. 1 A 3D perfused bioreactor that is designed with silicon wafer scaffolds combined with a cell-retaining filter and support in reactor housing to perfusate flow rates meets estimated values of cellular oxygen demands and provides fluid shear at or below a physiological range. Primary rat hepatocytes cultured for up to 2 wk were rearranged extensively to form tissue-like structures and remained viable throughout the culture period. 31 A gelatin and gum Arabic gel system was used to develop a packed bed perfusion bioreactor comprised of a chamber containing chlorogenic acid scaffolds in the form of a circular disc as the packed bed column for hepatocytes. The cultured hepatocytes maintained liver-specific functions for 7 d.
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Silk fibroin-gelatin 3D scaffolds designed with a biomimetic vascular tree of rat liver incorporated parameters of blood vessels, such as branching angle and diameter. These scaffolds were fabricated by combining micromoulding, freeze drying, 3D rolling techniques, nonchannel scaffolds, and nonbranch scaffolds seeded with hepatocytes. The biomimetic vascular tree network enhanced mass transport, produced a better structural property of facilitating fluid flow, and had greater cell density in comparison to nonchannel and nonbranch scaffolds. 27 An in vitro 3D cell culture model of human nonalcoholic fatty liver disease was developed with primary hepatocytes cultured in a LiverChip ® (CN BioInnovations, Welwyn Garden City, Hertfordshire UK) 3D perfused cell culture system containing 12 independent bioreactors of collagen I-coated scaffolds for the 3D culture of hepatocytes and to subsequently form 3D microtissue structures. These hepatocytes revealed fat uptake during 14-d culture. Hepatocytes cultured under fatty conditions and treated with metformin showed reduced cellular fat content compared to untreated controls. 33 A variety of cultures and methods has been developed to foster retention of hepatocytic function; still, not all critical liver functions can yet be replicated at desired levels. However, the reactor design for 3D perfusion culture should ensure a relatively homogeneous distribution of flow and mass transfer throughout the system to meet metabolic demands of cells.
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IV. LIVER-ON-CHIP
Models of 3D cell culture often promote levels of cell differentiation and tissue organization that are not possible in conventional 2D culture systems. But even they fail to reconstitute features of living organs that are critical for function. The shortcomings of existing 2D and 3D culture systems are largely the result of time-consuming and costly animal studies. 34 One main category of dynamic in vitro models is organs on chips ( Table 3 ) that provide insights on microfabrication technologies and microfluidic approaches to create cell culture microenvironments that support tissue differentiation, recapitulate tissue-tissue interfaces, and replicate mechanical microenvironments of living organs. These organs on chip permit study of human physiology in an organ-specific context, enable development of novel in vitro disease models, and may potentially serve as replacements for animals used in drug development, toxin testing, 34 and screening for biothreat and chemical warfare agents. 35 Organon-chips miniature structures are tailored down to the scale of single cells to create controllable microtissue environments, in which cells express in vivolike specific functionalities. 36 Liver-on-chip tissue models (Fig. 3) for drug screening are immensely important because of high frequency drug-induced liver injury. 3D-engineered tissues encapsulated into a microfluidic device can mimic in vivo structure, function, and responses to drugs in human tissues more accurately than 2D models, leading to better in vitro efficacy and safety screening before human trials. 37 Despite significant
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advances in design and demonstration of individual organ-on-chip systems, appropriate scaling laws, universal cell culture media, precise control of microliter-size volume circulation, real-time monitoring, and dynamic measurements are some of the demands of realistic human organ-on-chip models.
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A 3D liver organoid formed with ECs, primary macrophages, and hepatocyte-like HepaRG 7 A microfluidic chip was designed to replicate culture of primary hepatocytes, with a single microfluidic sinusoid having three fluid terminals of flow inlet and outlet and cell inlet. The cell culture area was separated from nutrient transport by a set of parallel microfluidic channels that acted as a microfluidic endothelial-like barrier to concentrate cells in the culture area, minimize convective flow through the cell culture region, and allow diffusive transport. The microscale culture unit imitated many mass transport properties of a functional liver sinusoid such as extensive cell-cell contact, defined tissue and fluid transport regions, and continuous nutrient exchange. Primary rat and human hepatocytes were maintained in this format for 7 d without diminished viability. 38 A very large-scale liver lobule-on-chip device was designed that consisted of an integrated network of liver lobule-like hexagonal tissue-culture chambers that replicated transport properties and fenestrated ECs of the liver. The device was constructed with a hybrid layout and had a separate seed-feed network mimicking blood circulation in the central vein of a liver lobule. Hep G2 cells and iPSC-derived hepatocytes that were cultured in the device maintained morphology and functionality. 3D Tissue-like structure and bile-canaliculi network formation were observed in the chips.
36 A liver-onchip platform, enabling bioprinting of hepatocyte spheroid-laden hydrogel constructs directly within the culture chamber of a perfusable bioreactor, was developed. The bioprinted 3D human Hep G2/C3A spheroids were incubated and remained viable and active during a 30-d culture period. Treatment with acetaminophen induced a toxic response in the hepatic construct that was similar to that in in vitro models and animal studies. 35 A microfluidic device was designed that consisting of four circular chambers and addressable inlet and outlet. The channel structures produced using 3D printing of PDMS. Hep G2 cells mixed with an ultraviolet cross-linkable HA-gelatin-based hydrogel solution were introduced into parallel channels of a sealed microfluidic device and photopatterned to produce stable tissue constructs in situ. The constructs remain stable and functional in the device during 7-d culture under recirculating media flow. When the constructs were exposed to ethyl alcohol, cell viability, urea secretion, and albumin levels decreased with increasing alcohol exposure. 39 A 3D liver micro-organ was designed to fabricate a microscale in vitro device housing a chamber of bioprinted 3D Hep G2 cells that were encapsulated in alginate-based tissue constructs. The liver micro-organ was characterized biologically for suitability as an in vitro drug metabolism platform under continuous perfusion flow and was found to be significant in metabolic conversion of drug. 40 It is also likely that mimicking in vivo liver sinusoidal (LS) architecture-the most basic functional unit of the liver-can produce useful results. The liver sinusoid is a capillary that is lined by LSECs. Stellate cells that help to maintain the ECM and Kupffer cells (liver macrophages) are also present. The space of Disse separates LSECs from hepatocytes. Bile canaliculi are small channels that form between adjacent hepatocytes. Hepatocytes secrete bile that is collected in a bile duct, transported to the intestines, or stored in the gallbladder. 41 A novel liver model attempted to mimic the liver sinusoid, where in a layered coculture of primary rat hepatocytes and primary rat LSECs or bovine aortic ECs (BAECs) were performed on a transwell membrane. When a layered coculture was attempted with a thin Matrigel layer placed between hepatocytes and ECs to mimic the space of Disse, the cells did not form completely separated monolayers. However, when hepatocytes and ECs were cultured on opposite sides of a transwell membrane, hepatocytes cocultured with LSECs or BAECs maintained their viability and normal morphology for 39 and 57 d, respectively. Long-term hepatic differentiation of hepatocytes was confirmed with urea synthesis cytochrome P450 expression.
V. BIOPRINTED LIVER
In the field of biofabrication, major advances are being made in fabricating 3D tissues and organs with very fine spatial control of cell deposition. Complex structures such as tissues and organs are printed by a bioprinter that has the ability to transfer microscopic patterns of viable cells of multiple cell types into well-defined 3D arrays (Fig. 4) . Cell stress and viability are still major concerns with bioprinting despite advanced printing technology. For example, cells printed by noncontact methods are affected when they impact on the substrate at some incident velocity, which results in extreme deceleration and shear stress. 8 When bioprinted, iPSCs and pluripotent ESCs revealed their differentiation into HLC lineage. Both ESCs and iPSCs are found to possess negligible differences in terms of viability and pluripotency between printed and nonprinted cells. Later, ESC-derived HLCs were 3D printed using an alginate hydrogel matrix and were found to be hepatic in nature, with peak albumin secretion at 21 d of the differentiation protocol. 8 A 3D hydrogel-based triculture model enabling iPSCs and hematopoietic progenitor cells (HPCs), with human umbilical vein ECs and adipose-derived stem cells in a microscale hexagonal architecture, showed phenotypic and functional enhancements in iPSCs and HPCs during weeks of in vitro culture. The developed 3D biomimetic liver model recapitulates the native liver module architecture and could be used for various applications such as early drug screening and disease modeling. 42 One of the limitations of current approaches is to accurately recapitulate the sophisticated liver microenvironment contributed by the complex microarchitecture and diverse cell combination. 42 Using collagen as bioink for printing, a mixture of primary rat hepatocytes, human umbilical vein ECs, and human lung fibroblasts were 3D printed on poly(ε-caprolactone) to form a capillary-like network. ing, Tewksbury, MA, USA) plates. The 3D liver tissues maintained cells for up to 4 wk in culture. To assess the ability of 3D liver cultures to model tissue level drug-induced liver injury, dose responses of trovafloxacin, a drug whose hepatotoxic potential could not be assessed by standard preclinical models, were compared to the structurally related nontoxic drug levofloxacin. Trovafloxacin induced significant, dose-dependent toxicity at clinically relevant doses. 44 Hep G2/C3A cells were cultured in PDMS microwells to form spheroids and later harvested to mix with a solution of gelatin methacryloyl and 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone hydrogel. The bioink printed as liquid droplets on a glass slide in the cell culture chamber of the bioreactor using a NovoGen MMX Bioprinter (Organovo Inc.). These engineered hepatic constructs remained functional for 30 d of continuous perfusion during the culture period. Treatment of these hepatic constructs with 15 mm acetaminophen induced a toxic response in the hepatic construct. 
A. BioPrinted Liver: Drug Toxicity and Hepatectomy
The current drug development process suffers from a high failure rate during clinical trials that is partly due to inadequacy of animal models to accurately predict toxic side effects of drugs in humans. Thus, there is a need to develop better predictive platforms for drug toxicity study. 35 Complex surgery always needs preoperative evaluation and practice to ensure success. Liver resection is the only successful treatment available for liver cancer, and accurately locating blood vessels in the liver, bile duct, and tumor is imperative. A patient-specific 3D printed liver model (Fig. 5) was developed for preoperative planning. 45 Anatomy data were segmented and extracted from computed tomography (CT) and magnetic resonance imaging of the liver from a patient with a sizable liver tumor. Digital data of the extracted anatomical surfaces were then edited and smoothed using Amira software (Zuse Institute Berlin; Thermo Fisher Scientific), resulting in a set of digital 3D models of hepatic vein, portal vein with tumor, biliary tree with gallbladder, and hepatic artery. The STL file of the final digital set was then 3D printed. The models of the biliary tree with gallbladder and hepatic artery were manufactured using TangoPlus (Stratasys; Eden Prairie, MN), which gave the models a soft, rubbery, and elastic texture. Models representing hepatic vein and portal vein with tumor were FIG. 5: 3D printed liver module. Schematic representation can be used for various hepatic applications printed using TangloBlack (Stratasys), giving the object a more rigid texture. The resulting models could complement the preoperative planning of hepatic resection by displaying the complex geometry of vascular, biliary, and malignant liver structures. The limitations mentioned in this study include data errors that resulted in artifacts and digital model inaccuracies that necessitated the need for digital editing to make the final 3D product printable and more realistic looking. 45 The 3D printed liver model is expensive, averaging $2000, and taking ~ 40 h to print at 100%. In addition, the visibility of inner structures is hindered due to transparent loading material and light refraction.
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The novel 3D printed liver model, which has been used to perform hepatectomy, is able to clearly simulate the resection line and safely perform the surgery.
46 A 3D liver model developed with anatomical structures including inferior vena cava, liver, tumor, portal veins, and hepatic veins was digitally segmented from CT images using SYNAPSE VIN-CENT (Fukifilm Corp.; Tokyo, Japan). Multidetector CT images were acquired using a Brilliance iCT Elite (Philips; Amsterdam, The Netherlands). All segmented data were converted to a STL file, and a 3D printed liver was fabricated using polyamide 12. To reduce cost, the model did not use transparent loading material; fabricated at 50% scale, it was sufficient to confirm anatomical construction and easily handled by surgeons. The cost was ~ $2600.00. 46 A transparent, full-sized liver model with visible vessels and colorectal metastasis was created for less than $150 with the help of low-cost fused deposition modeling printing technique and silicone, but printing occurred at a slower pace (60-100 h).
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The 3D model (Table 4) , expected to be beneficial, will be used for general and gastrointestinal surgery. Presurgical guides are considered to be particularly helpful for procedures requiring highly accurate visualization of anatomy and more favorable than a standard imaging technique. Such models lead to shorter operative and recovery time, reduced blood loss, and better resection margins.
VI. CONCLUSIONS AND FUTURE PERSPECTIVE
Exciting results from tissue engineering and regenerative medicine have brought a new era of valuable research and applications for the field of medicine. Engineered biomimetic 3D constructs can keep hu- For 3D printing, low-cost variants of hardware, software, and printing materials could decrease cost. Imaging and data processing times can be decreased to minutes with development of imaging software. The limitation of model size can be overcome by dividing models into small parts and combining parts after printing or by producing a miniature version of large structures via postprocessing. The combination of cell biology and microengineering could recapitulate organ level functionality. Primary challenges to achieving such a goal include reconstituting appropriate tissue microarchitecture, complex biochemical milieu, and dynamic mechanical microenvironment. However, strategies of microfabrication and microfluidics are well suited to meet these challenges because they provide dynamic control of structure, mechanics, and chemical delivery on a cellular size scale.
With a myriad of developments in the field of liver tissue engineering, some key issues such as gene expression of multiple liver cell types in an engineered platform over time must be compared to freshly isolated cells. This will elucidate pathways that maintain physiological levels in culture, clarify the use of specific biomarkers to validate the utility of engineered liver platforms for drug screening, identify the potential and reliability of iPSCs-derived human liver cells. All of these must be addressed in next-generation platforms. The new developments in biomimetic 3D constructs, bioengineered 3D microsystems, organ-on-chip technologies, bioreactor systems, and bioprinted liver can act as torchbearers for achieving new heights in repair and generation of liver tissues.
